Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Improving Brain Tumor Segmentation at the Edge

Intel’s Abhishek Khowala, principal health AI engineer, and Séverine Habert, AI engineering manager, discuss some of the enhancements in brain tumor segmentation for enabling diagnosis. While most brain tumors are benign, early detection is critical for the best treatment options and outcomes. Assessing a diagnosis starts with MRI 2D and 3D imaging. Segmentation of…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

Share

Intel’s Abhishek Khowala, principal health AI engineer, and Séverine Habert, AI engineering manager, discuss some of the enhancements in brain tumor segmentation for enabling diagnosis.

While most brain tumors are benign, early detection is critical for the best treatment options and outcomes. Assessing a diagnosis starts with MRI 2D and 3D imaging. Segmentation of the brain tumor – or separating the tumor from normal brain tissues – is essential to identifying three key factors to allow doctors to move forward:

  1. Is the tumor benign or malignant?
  2. The approximate tumor size and location.
  3. Plan out the treatment options.

“We need to segment out the tumor from the rest of the tissues around it,” Khowala says. “For that, there is the unit model. And that architecture works with fewer amounts of data yet provides a clearer segmentation result.”

The brain tumor segmentation (BraTS) combined with OpenVINO™ toolkit could optimize MRI results during tumor detection and monitoring. “Since this is something that has to happen worldwide, we need to deploy it at scale,” Khowala explains. Scaling requires overcoming a few challenges. Utilizing OpenVINO erases issues of high-cost GPU required for deploying AI solutions or perceived performance limitations of common frameworks such as PyTorch or TensorFlow. “Brain tumor segmentation is a perfect example of applying the most common architecture and using it for multiple devices from edge to handheld devices,” Habert adds.

For optimized AI, the provided data must be robust, which is not an easy task. According to Khowala, Expert radiologists are required to interpret the MRI images to get to the ground truth data. BraTS helps predict results and compare accuracy with provided ground truth results using the Sørensen–Dice coefficient datasets. Once the data is available, modeling can take place and assist medical professionals in their diagnosis.

Learn more about brain tumor segmentation solutions by connecting with Abhishek Khowala and Séverine Habert on LinkedIn or visit:

https://www.intel.com/content/www/us/en/healthcare-it/healthcare-overview.html.

Subscribe to this channel on Apple Podcasts, Spotify, and Google Podcasts to hear more from the Intel Internet of Things Group.

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

CMS centralizes health tech authority in new office covering AI, interoperability, and claims modernization

CMS centralizes health tech authority in new office covering AI, interoperability, and claims modernization

The Centers for Medicare & Medicaid Services (CMS) has established a new Office of Health Technology and Products. This office assumes over 90 responsibilities to lead federal health IT strategy, focusing on areas like AI, interoperability, and claims modernization.

  • 01CMS's new office centralizes health tech authority, focusing on AI and interoperability.
  • 02The office takes on over 90 responsibilities to modernize claims processes.
  • 03CMS aims to lead federal health IT strategy with its new dedicated office.

Aug 1, 2026

Rebuilding Medicine Around Presence: The Future of Physician House Calls with Dr. Yevhen Pavelko, Founder of Inviah Health

Dr. Yevhen Pavelko, founder of Inviah Health, is advocating for the resurgence of physician house calls. He believes that personal interaction can significantly improve patient care and satisfaction. Inviah Health aims to modernize this traditional approach by integrating advanced medical technology.

  • 01Dr. Yevhen Pavelko supports the revival of physician house calls to improve patient care.
  • 02Inviah Health focuses on integrating advanced technology with traditional house call practices.
  • 03Personal interaction between doctors and patients can enhance care and satisfaction.

Jul 31, 2026

Tempus AI's $1.7B Personalis deal leads a surge in health-tech M&A that is already reshaping vendor choices for health system operators

Tempus AI's $1.7B Personalis deal leads a surge in health-tech M&A that is already reshaping vendor choices for health system operators

Digital health mergers and acquisitions (M&A) along with venture capital (VC) activities are rapidly increasing. Tempus AI's $1.7 billion acquisition of Personalis is part of a larger trend that is influencing health system operators’ selection of vendors. With $7.4 billion in funding during the first half of 2026, the health-tech industry is undergoing significant transformation.

  • 01Tempus AI acquired Personalis for $1.7 billion.
  • 02Health-tech received $7.4 billion in funding in the first half of 2026.
  • 03M&A activities are influencing vendor choices for health system operators.

Jul 30, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512